{"cluster": 62, "subcluster": 5, "abstract_summ": "Here we demonstrate that the antiparasitic drug suramin inhibits SARS-CoV-2 replication, protecting Vero E6 cells with an EC50 of \u223c20 \u03bcM, which is well below the maximum attainable level in human serum.Here we demonstrate that the antiparasitic drug suramin inhibits SARS-CoV-2 replication, protecting Vero E6 cells with an EC50 of \u223c20 \u00b5M, which is well below the maximum attainable level in human serum.Suramin also decreased the viral load by 2-3 logs when Vero E6 cells or cells of a human lung epithelial cell line (Calu-3) were treated.Suramin also decreased the viral load by 2-3 logs when Vero E6 cells or cells of a human lung epithelial cell line (Calu-3) were treated.Both drugs completely inhibited the cytopathic effect (CPE) produced by SARS-CoV-2 infection at lower drug concentrations than that of remdesivir.", "title_summ": "Indomethacin has a potent antiviral activity against SARS CoV-2 in vitro and canine coronavirus in vivoInhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazineSuramin inhibits SARS-CoV-2 infection in cell culture by interfering with early steps of the replication cycleBroad-spectrum antiviral activity of naproxen: from Influenza A to SARS-CoV-2 CoronavirusPotent antiviral effect of protoporphyrin IX and verteporfin on SARS-CoV-2 infectionIn Vitro Inhibition of SARS-CoV-2 Infection by Bovine LactoferrinAn in vitro assessment of anti-SARS-CoV-2 activity of oral preparations of iodine complexes (RENESSANS)The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitroRepurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like proteaseIn-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming FormulationsGemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture.Suramin inhibits SARS-CoV-2 infection in cell culture by interfering with early steps of the replication cycle.Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2.An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening.", "title_abstract_phrases": "Our results demonstrate that broad-spectrum antiviral compounds may have a priority for the screening of antiviral compounds against newly emerging viruses to control viral infection.Here we demonstrate that the antiparasitic drug suramin inhibits SARS-CoV-2 replication, protecting Vero E6 cells with an EC50 of \u223c20 \u03bcM, which is well below the maximum attainable level in human serum.Here we demonstrate that the antiparasitic drug suramin inhibits SARS-CoV-2 replication, protecting Vero E6 cells with an EC50 of \u223c20 \u00b5M, which is well below the maximum attainable level in human serum.Suramin also decreased the viral load by 2-3 logs when Vero E6 cells or cells of a human lung epithelial cell line (Calu-3) were treated.Suramin also decreased the viral load by 2-3 logs when Vero E6 cells or cells of a human lung epithelial cell line (Calu-3) were treated."}